Correlation Between Kymera Therapeutics and Taxus Cardium
Can any of the company-specific risk be diversified away by investing in both Kymera Therapeutics and Taxus Cardium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kymera Therapeutics and Taxus Cardium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kymera Therapeutics and Taxus Cardium Pharmaceuticals, you can compare the effects of market volatilities on Kymera Therapeutics and Taxus Cardium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kymera Therapeutics with a short position of Taxus Cardium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kymera Therapeutics and Taxus Cardium.
Diversification Opportunities for Kymera Therapeutics and Taxus Cardium
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Kymera and Taxus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and Taxus Cardium Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taxus Cardium Pharma and Kymera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kymera Therapeutics are associated (or correlated) with Taxus Cardium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taxus Cardium Pharma has no effect on the direction of Kymera Therapeutics i.e., Kymera Therapeutics and Taxus Cardium go up and down completely randomly.
Pair Corralation between Kymera Therapeutics and Taxus Cardium
If you would invest 2,914 in Kymera Therapeutics on September 19, 2024 and sell it today you would earn a total of 1,316 from holding Kymera Therapeutics or generate 45.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.26% |
| Values | Daily Returns |
Kymera Therapeutics vs. Taxus Cardium Pharmaceuticals
Performance |
| Timeline |
| Kymera Therapeutics |
| Taxus Cardium Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Kymera Therapeutics and Taxus Cardium Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kymera Therapeutics and Taxus Cardium
The main advantage of trading using opposite Kymera Therapeutics and Taxus Cardium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kymera Therapeutics position performs unexpectedly, Taxus Cardium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taxus Cardium will offset losses from the drop in Taxus Cardium's long position.| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
| Taxus Cardium vs. Revolution Medicines | Taxus Cardium vs. Blueprint Medicines Corp | Taxus Cardium vs. Sana Biotechnology | Taxus Cardium vs. Kymera Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |